.png){kind=icon}
.png){kind=icon}
Return
Long-term risk of total joint replacement associated with second-line glucose-lowering therapies in type 2 diabetes: A population-based retrospective cohort study
.png){kind=icon}
PRE
AI
C
H
C
C
H
DOI：10.1016/j.semarthrit.2026.152995.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To evaluate whether initiation of different second-line glucose-lowering therapies is associated with the risk of total joint replacement (TJR) among patients with type 2 diabetes (T2DM).
Keywords:
type 2 diabetes
second-line glucose-lowering therapies
total joint replacement
retrospective cohort study
diabetes management
Journal
IF:
4.4
Papers:
423
Citations:
1.0W
Organization
Cited Papers